Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01619007
Recruitment Status : Completed
First Posted : June 14, 2012
Last Update Posted : January 23, 2017
Janssen Research & Development, LLC
Information provided by (Responsible Party):